Stout Jay S 4
4 · Immunovant, Inc. · Filed Apr 19, 2023
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Stout Jay S
Chief Technology Officer
Transactions
- Award
Common Stock
2023-04-17+100,000→ 100,000 total - Award
Stock Option (right to buy)
2023-04-17+150,000→ 150,000 totalExercise: $15.47Exp: 2033-04-17→ Common Stock (150,000 underlying)
Footnotes (3)
- [F1]Represents the number of shares underlying restricted stock units awards ("RSUs").
- [F2]The RSUs vest over four years, with 25% of the RSUs vesting on April 17, 2024 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
- [F3]Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 17, 2024 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.